No Data
Verona Pharma Management to Meet With BTIG
Verona Pharma Insider Sold Shares Worth $618,658, According to a Recent SEC Filing
Express News | HC Wainwright & Co. Maintains Buy on Verona Pharma, Raises Price Target to $42
Verona Pharma Is Maintained at Buy by Canaccord Genuity
A Quick Look at Today's Ratings for Verona Pharma(VRNA.US), With a Forecast Between $42 to $64
Verona Pharma Receives Buy Rating Amid Strong Financial Performance and Growth Prospects
loading...
loading...